<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Ispire Technology Inc. Common Stock — News on 6ix</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock</link>
<description>Latest news and press releases for Ispire Technology Inc. Common Stock on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 23 Apr 2026 12:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/ispire-technology-inc-common-stock" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835859d78dffbe2df0fd95d.webp</url>
<title>Ispire Technology Inc. Common Stock</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock</link>
</image>
<item>
<title>IKETech Wins "Privacy-Centric Age Assurance Solution of the Year," Recognized for Innovation at Global Industry Awards</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/iketech-wins-privacy-centric-age-assurance-solution-of-the-year-recognized-for-innovation-at-global-industry-awards</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/iketech-wins-privacy-centric-age-assurance-solution-of-the-year-recognized-for-innovation-at-global-industry-awards</guid>
<pubDate>Thu, 23 Apr 2026 12:30:00 GMT</pubDate>
<description>IKETech LLC, an AI-powered compliance infrastructure company and joint venture among Ispire Technology Inc. (NASDAQ: ISPR), Berify, and Chemular Inc., announced it has received dual recognition at the Age Assurance Industry Awards 2026, presented at the Global Age Assurance Standards Summit (GAAS) in Manchester, UK.</description>
</item>
<item>
<title>Ispire Highlights Economic Impact of New FDA Guidance on Flavored ENDS Unlocking a $50 Billion Market and Driving Significant Potential Asset Value</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-highlights-economic-impact-of-new-fda-guidance-on-flavored-ends-unlocking-a-dollar50-billion-market-and-driving-significant-potential-asset-value</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-highlights-economic-impact-of-new-fda-guidance-on-flavored-ends-unlocking-a-dollar50-billion-market-and-driving-significant-potential-asset-value</guid>
<pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
<description>Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, today highlighted the massive economic value and multi-billion-dollar market opportunity created for its shareholders by the U.S. Food and Drug Administration's (FDA) newly issued draft guidance outlining evidentiary expectations for Premarket Tobacco Product Applications (PMTAs) for flavored electronic nicotine delivery systems (ENDS).</description>
</item>
<item>
<title>Ispire Technology Inc. to Participate in the 38th Annual ROTH Conference</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-to-participate-in-the-38th-annual-roth-conference</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-to-participate-in-the-38th-annual-roth-conference</guid>
<pubDate>Wed, 11 Mar 2026 11:00:00 GMT</pubDate>
<description>Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today announced that Ispire's management team will participate in the 38th Annual ROTH Conference taking place in Dana Point, California from March 22-24, 2026.</description>
</item>
<item>
<title>Ispire Technology Inc. Reports Financial Results for Fiscal Second Quarter 2026</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-reports-financial-120000238</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-reports-financial-120000238</guid>
<pubDate>Fri, 06 Feb 2026 12:00:00 GMT</pubDate>
<description>Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today reported financial results for the second quarter of fiscal 2026, for the three months ended December 31, 2025.</description>
</item>
<item>
<title>Ispire-Backed IKE Tech Invited to Participate in FDA Roundtable on PMTA Submissions</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-backed-ike-tech-invited-133000071</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-backed-ike-tech-invited-133000071</guid>
<pubDate>Wed, 04 Feb 2026 13:30:00 GMT</pubDate>
<description>Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced that IKE Tech LLC ("IKE Tech" or "IKE"), a joint venture that includes Ispire as a founding partner, has been invited by the U.S. Food and Drug Administration (FDA) to participate in its Roundtable Discussion with Small ENDS Manufacturers on Premarket Tobacco Product Application (PMTA) Submissions.</description>
</item>
<item>
<title>Ispire Technology Inc. Schedules Fiscal Second Quarter 2026 Earnings Conference Call</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-schedules-fiscal-120000948</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-schedules-fiscal-120000948</guid>
<pubDate>Tue, 03 Feb 2026 12:00:00 GMT</pubDate>
<description>Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will host its earnings conference call at 8:00 am ET on Friday, February 6, 2026, to discuss the Company's financial results for its fiscal second quarter ended December 31, 2025.</description>
</item>
<item>
<title>Ispire Technology Unveils Next-Gen Cannabis Hardware Ecosystem at MJBizCon 2025</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-unveils-next-gen-223400513</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-unveils-next-gen-223400513</guid>
<pubDate>Wed, 26 Nov 2025 22:34:00 GMT</pubDate>
<description>Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," or the "Company"), announced that it will unveil its fully reengineered cannabis product ecosystem at MJBizCon 2025, the world's largest cannabis industry conference and trade show. Held December 2–5 at the Las Vegas Convention Center, the event will serve as the official launchpad for Ispire's next-generation hardware suite.</description>
</item>
<item>
<title>Ispire Technology and IKE Tech Applaud FDA Crackdown, Call for Tech-Driven Enforcement to Prevent Illicit Trade and Protect Youth</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-ike-tech-applaud-133000063</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-ike-tech-applaud-133000063</guid>
<pubDate>Mon, 17 Nov 2025 13:30:00 GMT</pubDate>
<description>Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), an innovator in vaping technology and precision dosing, and IKE Tech LLC ("IKE Tech"), a joint venture that includes Ispire as a founding partner, released statements following the U.S. Food and Drug Administration's (FDA) Congressional funding and directive to combat the illicit vape market.</description>
</item>
<item>
<title>Ispire Technology Inc. Reports Financial Results for Fiscal First Quarter 2026</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-reports-financial-120000971</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-reports-financial-120000971</guid>
<pubDate>Thu, 06 Nov 2025 12:00:00 GMT</pubDate>
<description>Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today reported financial results for the first quarter of fiscal 2026, for the three months ended September 30, 2025.</description>
</item>
<item>
<title>Ispire Technology Inc. Schedules Fiscal First Quarter 2026 Earnings Conference Call</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-schedules-fiscal-210500544</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-schedules-fiscal-210500544</guid>
<pubDate>Tue, 04 Nov 2025 21:05:00 GMT</pubDate>
<description>Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will host its earnings conference call at 8:00 am ET on Thursday, November 6, 2025, to discuss the Company's financial results for its fiscal first quarter ended September 30, 2025.</description>
</item>
<item>
<title>Ispire Technology Inc. to Participate in Upcoming October Conferences</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-participate-upcoming-110000125</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-participate-upcoming-110000125</guid>
<pubDate>Wed, 15 Oct 2025 11:00:00 GMT</pubDate>
<description>Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today announced that Ispire Technology Inc.'s management team is scheduled to participate in the following October 2025 investor conferences.</description>
</item>
<item>
<title>Ispire Technology Inc. Reports Financial Results for the Fiscal Year 2025</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-reports-financial-110000340</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-reports-financial-110000340</guid>
<pubDate>Tue, 16 Sep 2025 11:00:00 GMT</pubDate>
<description>Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today reported results for the fiscal year 2025, which ended on June 30, 2025.</description>
</item>
<item>
<title>Ispire Technology Inc. Schedules Fiscal Fourth Quarter and Full Year 2025 Earnings Conference Call</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-schedules-fiscal-200500309</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-schedules-fiscal-200500309</guid>
<pubDate>Fri, 12 Sep 2025 20:05:00 GMT</pubDate>
<description>Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will host its earnings conference call at 8:00am ET on Tuesday, September 16, 2025, to discuss the Company's financial results for its fiscal fourth quarter and full year ended June 30, 2025.</description>
</item>
<item>
<title>Ispire-Backed IKE Tech to Spotlight Breakthroughs in Vape Safety and Harm Reduction at World Vape Show Dubai</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-backed-ike-tech-to-spotlight-breakthroughs-in-vape-safety-and-harm-reduction-at-world-vape-show-dubai</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-backed-ike-tech-to-spotlight-breakthroughs-in-vape-safety-and-harm-reduction-at-world-vape-show-dubai</guid>
<pubDate>Mon, 16 Jun 2025 12:30:00 GMT</pubDate>
<description>Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a global leader in vaporization technology and precision dosing, announced its joint venture IKE Tech LLC ("IKE Tech") will spotlight Ike Tech's blockchain based point of use age-gating and Smart-Tag authentication technologies at the World Vape Show Dubai, June 18–20, 2025.</description>
</item>
<item>
<title>Ispire to Participate in the Benzinga Cannabis Capital Conference in Chicago on Tuesday, June 10, 2025</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-participate-benzinga-cannabis-capital-123000076</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-participate-benzinga-cannabis-capital-123000076</guid>
<pubDate>Fri, 06 Jun 2025 12:30:00 GMT</pubDate>
<description>Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced that the Company will participate in the Benzinga Cannabis Capital Conference, taking place from June 10-11, 2025, at the Marriott Magnificent Mile in Chicago, Illinois.</description>
</item>
<item>
<title>Ispire-Backed IKE Tech to Present 7th Annual Next Generation Nicotine Delivery USA Conference</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-backed-ike-tech-to-present-7th-annual-next-generation-nicotine-delivery-usa-conference</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-backed-ike-tech-to-present-7th-annual-next-generation-nicotine-delivery-usa-conference</guid>
<pubDate>Tue, 03 Jun 2025 12:00:00 GMT</pubDate>
<description>Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced that IKE Tech LLC ("IKE Tech"), a joint venture that includes Ispire as a founding partner, will showcase their technology at the 7th Annual Next Generation Nicotine Delivery USA at the Hyatt Regency in Miami from June 4-5th. This event convenes key business leaders from the FDA, the ENDS (Electronic Nicotine Delivery Systems) sector, and the tobacco industry acro</description>
</item>
<item>
<title>Ispire Technology Inc. Announces Approval of Interim License for Manufacturing of Nicotine Products in Malaysia</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-announces-approval-130000680</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-announces-approval-130000680</guid>
<pubDate>Thu, 22 May 2025 13:00:00 GMT</pubDate>
<description>Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today announced it has received the interim license from the Malaysian Government for the manufacturing of nicotine products. This is the first and only nicotine manufacturing license issued in Malaysia approved by both the Federal and State authorities and cements Ispire's position as the only company with full authorization for export, import, and produ</description>
</item>
<item>
<title>Ispire Technology Inc. Announces Appointment of Jay Yu as Chief Financial Officer</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-announces-appointment-203000273</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-announces-appointment-203000273</guid>
<pubDate>Thu, 15 May 2025 20:30:00 GMT</pubDate>
<description>Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today announced the appointment of Jie "Jay" Yu as the new Chief Financial Officer of the Company, effective immediately, following the departure of Jim McCormick, the former Chief Financial Officer of the Company. Ispire also announced that it continued to further streamline its overall operations as the Company reduced its workforce and ended several co</description>
</item>
<item>
<title>Ispire Technology Inc. Reports Financial Results for Fiscal Third Quarter 2025</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-reports-financial-results-for-fiscal-third-quarter-2025</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technology-inc-reports-financial-results-for-fiscal-third-quarter-2025</guid>
<pubDate>Mon, 12 May 2025 04:00:00 GMT</pubDate>
<description>Accounts Receivable Decreased from $67.7M to $60.4M Improving Company Financial PositionPost-Quarter End, IKE Tech Filed PMTA with the FDA for its Age-Gating</description>
</item>
<item>
<title>Ispire Technologies Inc. Schedules Fiscal Third Quarter 2025 Earnings Conference Call</title>
<link>https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technologies-inc-schedules-fiscal-203000909</link>
<guid isPermaLink="true">https://6ix.com/company/ispire-technology-inc-common-stock/news/ispire-technologies-inc-schedules-fiscal-203000909</guid>
<pubDate>Wed, 07 May 2025 20:30:00 GMT</pubDate>
<description>Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will host its earnings conference call at 8:00am ET on Monday, May 12, 2025, to discuss the Company's financial results for the fiscal third quarter ended March 31, 2025.</description>
</item>
</channel>
</rss>